Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zoetis Inc    ZTS

ZOETIS INC (ZTS)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about ZOETIS INC
09/07 ZOETIS : Makes EXAME Biggest & Best in Brazil List for Third Year
09/05 ZOETIS : Announces Pricing of $1.25 Billion of Senior Notes
08/31 TAKING OWNERSHIP OF YOUR CAREER DEVE : An Editorial by Roxanne Lagano
08/28 EARNINGS REVIEW AND FREE RESEARCH RE : Zoetis’ Results Beat Estimates in E..
08/20 ANATARA LIFESCIENCES LTD (ASX : ANR) and Zoetis to Negotiate Terms of Internatio..
08/08 ZOETIS : meets 2Q profit forecasts
08/08 ZOETIS INC. (NYSE : ZTS) Files An 8-K Results of Operations and Financial Condit..
08/08 ZOETIS : Announces Second Quarter 2017 Results
08/03 ZOETIS INC. (NYSE : ZTS) Files An 8-K Departure of Directors or Certain Officers..
08/03 ZOETIS : Appoints Dr. Linda Rhodes to Board of Directors
08/03ZOETIS INC : half-yearly earnings release
07/31 ZOETIS : Completes Acquisition of Nexvet Biopharma
07/12 GREAT LEADERSHIP DELIVERS GREAT RESU : An Editorial by Juan Ramón Alaix
07/12 ZOETIS : Joins Bac Vactory Collaboration to Develop Vaccines Against Diseases Ca..
06/30 ZOETIS : to Host Webcast and Conference Call on Second Quarter 2017 Financial Re..
More most relevant news
All news about ZOETIS INC
09/12 ZOETIS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
09/07 ZOETIS : Makes EXAME Biggest & Best in Brazil List for Third Year
09/05 ZOETIS : Announces Pricing of $1.25 Billion of Senior Notes
08/31 ANATARA LIFESCIENCES : and Zoetis to Negotiate Terms of an International Detach®..
08/31 TAKING OWNERSHIP OF YOUR CAREER DEVE : An Editorial by Roxanne Lagano
08/28 EARNINGS REVIEW AND FREE RESEARCH RE : Zoetis’ Results Beat Estimates in E..
08/28 ZOETIS INC : Earnings Review and Free Research Report: Zoetis’ Results Beat Esti..
08/24 ZOETIS : VCA Animal Hospitals and Zoetis Partner on a Successful Clinical Study ..
08/22 ZOETIS : Taurus Asset Management Continues To Keep Stake in Zoetis
08/20 ANATARA LIFESCIENCES LTD (ASX : ANR) and Zoetis to Negotiate Terms of Internatio..
More news
Sector news : Veterinary Drugs
06:35p Pfizer files suit against J&J over Remicade contracts
03:27pDJPFIZER : Files Antitrust Lawsuit Alleging J&J Thwarted Use of Biosimilar Rival t..
02:57pDJSANOFI : Alnylam Report Positive Patisiran Phase III Trial, First-Ever for RNAi ..
09:21a GLAXOSMITHKLINE : GSK's new triple lung drug beats other modern inhalers in stud..
09:01aDJGLAXOSMITHKLINE : Announces Positive Results for Triple-Therapy Inhaler
08:48aDJMakers Of Opioids Are Asked For Data -- WSJ
More sector news : Veterinary Drugs
News from SeekingAlpha
09/15 Zoetis' International Acclaim Demands Attention
09/06 Zoetis prices $1.25B debt offering
08/31 Immunovaccine announces achievement of milestones in collaboration with Zoeti..
08/24 Diagnosing Merck (Part 2 Of 2)
08/22 Diagnosing Merck (Part 1 Of 2)
08/18 Zoetis 2017 Q2 - Results - Earnings Call Slides
Latest Tweets
07:09aZoetis downgraded by BidaskClub to buy.  
07:09aBidaskClub Lowers Zoetis Inc. $ZTS to Buy  
09/19Zoetis seeks Kalamazoo tax break for $64M manufacturing expansion  
09/16Traders Buy Zoetis Inc. $ZTS on Weakness  
09/16Somewhat Positive Media Coverage Somewhat Unlikely to Affect Zoetis $ZTS Shar.. 
More tweets
Qtime:110
Financials ($)
Sales 2017 5 194 M
EBIT 2017 1 774 M
Net income 2017 1 101 M
Debt 2017 3 534 M
Yield 2017 0,64%
P/E ratio 2017 29,64
P/E ratio 2018 24,91
EV / Sales 2017 6,78x
EV / Sales 2018 6,29x
Capitalization 31 685 M
Chart ZOETIS INC
Duration : Period :
Zoetis Inc Technical Analysis Chart | ZTS | US98978V1035 | 4-Traders
Technical analysis trends ZOETIS INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 67,1 $
Spread / Average Target 3,6%
EPS Revisions
Managers
NameTitle
Juan Ramón Alaix President, Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Kristin C. Peck Executive Vice President & President-US Operations
Glenn David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS INC21.80%31 685
JINYU BIO-TECHNOLOGY CO LTD49.34%3 307
DECHRA PHARMACEUTICALS PLC51.97%2 546
PHIBRO ANIMAL HEALTH CORP22.01%1 430
SHANGHAI HILE BIO-TECHNOLOGY CO LTD-25.14%1 313
VIRBAC-23.24%1 301